BioSpace News Archive

Press Releases

Segal Trials Leads Phase 2 Schizophrenia Trial of LB-102 Toward Primary Endpoint

January 22, 2025
·
3 min read
Press Releases

Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

January 22, 2025
·
7 min read
Press Releases

Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium

January 22, 2025
·
10 min read
Press Releases

Salubris Biotherapeutics Announces Positive Interim Data from the Phase 2 Trial of JK07 in Heart Failure

January 22, 2025
·
4 min read
Press Releases

IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment

January 22, 2025
·
6 min read
Press Releases

Intellia Therapeutics Announces First Patient Dosed in the HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema

January 22, 2025
·
6 min read
Press Releases

Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook

January 22, 2025
·
28 min read
Press Releases

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements

January 22, 2025
·
5 min read
Press Releases

Spectral AI Provides Update to Investors

January 22, 2025
·
4 min read
Press Releases

Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement

January 22, 2025
·
2 min read